retatrutide peptide triple hormone receptor agonist safety retatrutide clinical trial for metabolic dysfunction-associated steatotic liver disease: a Retatrutide (Triple-Action Jab): Phase III

Our Clinical Pharmacists recently wrapped up the 2026 Peptide World Congress, and one idea stuck with us: peptides are best understood as signaling molecules, not standalone fixes

Wang, Z.-P., Shang, X.-X

4 Concluding remarks, place in therapy, and future perspective Tirzepatide is a novel agent that is approved for the treatment of type 2 diabetes and will likely be approved for weight loss

Lampasona, V

EFS-C9 or CAG-C9 AG-haESCs were infected with lentivirus for ~48 h and then selected with puromycin for 48 h

Opt for natural, breathable fabrics like cotton or moisture-wicking materials that allow sweat to evaporate rather than accumulate